Tag Archives: Stellar Biotechnologies (KLH.TO SBOTF)

  • What’s “Neural Imprinting,” and will it really “wipe out pain and generate $2.86 trillion in new wealth?”

    This article originally appeared as part of the Friday File for the Stock Gumshoe Irregulars (our paid members) on November 20, 2015. The article has not been updated or revised, other than a couple quick updates to numbers and valuations, but we’ve had questions about the ad of late, so we’re moving it back to […]

  • Stellar Biotechnologies

    Does anyone have anything new on stellar, she took off, not sure if it’s just response to the newsletters or if somethings been disclosed I’m not aware of. I can not find any definitive reason beyond the news letters. It is a great story on this one, I bit at 1.21, thinking it might be […]

  • “Blue Blood” — Which “Tiny Biotech Owns Only Source of Rare Cancer-Curing Chemical?”

    The following article originally appeared on February 11, 2014 — several readers have asked about the “blue blood” pitch for this “cancer cure” (there’s a reason why we use quotes there) so we’re putting it on top of the page in case you’re curious. My opinion on this one is unchanged, I’m still pretty skeptical […]

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.